Averix Bio is a U.S.-based producer of cannabinoid extracts that comply with cGMP API Phytocannabinoid CBD standards outlined in 21 CFR Part 210 and Part 211 as well as ICH Q7. Averix Bio supplies premium cannabinoid ingredients for pharmaceutical, nutraceutical, food and beverage, and cosmetic applications, ensuring consistent quality from production to distribution and building a foundation based on traceability, openness, and confidence.